Home›The Treatise›Chapters›Chapter 57
Tratado de Cirurgia da Coluna Vertebral
SECTION 6 • Spine Tumors
Chapter57

RADIOTHERAPY IN SPINAL TUMORS

Vancouver: Hanriot RM, Gutierrez NS📖 Pages: 753-766
Full reading of this chapter is available exclusively in the printed edition of the Treatise.
Sec. 6Spine Tumors
Cap. 57Clinical Chapter
2authors
Português
Español
English
Referênciasscientific citations
📑

Chapter Summary

• Context: Radiotherapy occupies a central position in the contemporary management of spinal tumors, both in pain palliation and local control of metastases and select primary neoplasms. Technological advancements have profoundly transformed its ability to treat lesions adjacent to the spinal cord. Two-dimensional techniques have yielded to three-dimensional planning, intensity-modulated beam delivery, and image-guided radiotherapy, enabling the use of Stereotactic Body Radiation Therapy (SBRT) in carefully selected patients. However, higher precision does not eliminate the need to evaluate mechanical stability, epidural extension, oncological prognosis, and toxicity risks. This chapter integrates SINS, Tokuhashi score, and the Bilsky classification into radiation planning, demonstrating the progressive evolution of dose conformity and neural sparing in Figures 57.3 through 57.6. Artificial intelligence, proton therapy, and intraosseous radiotherapy are presented as emerging avenues for expanding therapeutic personalization.
• Chapter Objective: Understand the indications and limitations of radiotherapy in vertebral tumors, differentiate conventional from advanced modalities, and recognize the role of SBRT. The chapter also integrates mechanical stability, epidural compression, and prognosis into radiation decision-making, discusses complications, and presents emerging planning and delivery technologies.
• Radiotherapy as part of an integrated strategyThe presence of a tumor in the spine does not, in isolation, indicate a specific radiation modality. Histological type, extent, stability, neural compromise, prior treatments, and clinical objectives must be known. SINS, Tokuhashi, and Bilsky address different questions. Table 57.1 addresses stability; Table 57.2, prognosis; and Table 57.3, the degree of epidural compression. Used together, they help avoid treating only the tumor imaging without considering its mechanical and neurological repercussions.
• Imaging and planningMRI is essential for delineating tumor extension and neural involvement. CT provides detailed bony information and directly participates in radiation treatment planning. PET-CT adds systemic and metabolic staging. Table 57.4 summarizes the advantages and limitations of these modalities.
• Technological evolution of radiotherapyConventional radiotherapy exhibits lower ability to conform dose around critical structures. 3D conformal radiotherapy introduced CT-based planning. Intensity-Modulated Radiation Therapy (IMRT) expanded the capacity to modulate dose distribution, while Image-Guided Radiation Therapy (IGRT) allows real-time verification and positional correction. SBRT combines high precision and ablative doses delivered in a small number of fractions. Its delivery requires rigid immobilization, rigorous planning, and strict adherence to spinal cord tolerance limits.
• Tumor control versus spinal mechanicsRadiotherapy can produce excellent tumor control, but it does not correct an unstable spine. Mechanical evaluation must precede radiation when there is vertebral collapse, deformity, or load-bearing pain. Likewise, high-grade epidural compression may require separation surgery prior to radiotherapy.
• ToxicityRadiation myelopathy, post-radiation vertebral compression fracture, and transient pain flare are among the discussed complications. Table 57.5 presents the technical dose-volume constraints utilized in SBRT planning.
• New perspectivesArtificial intelligence applied to contouring and risk prediction, proton therapy, combination with immunotherapy, and intraosseous radiotherapy represent evolving technologies. Figures 57.7 and 57.8 illustrate an intraosseous radiation delivery strategy combined with percutaneous vertebral augmentation.
• Clinical Application: Before referring a patient directly for radiotherapy, one must determine whether the primary threat is oncological, mechanical, or neurological. A painful lesion in a stable spine represents a vastly different scenario from a metastasis with progressive deformity or high-grade epidural compression. SINS identifies patients requiring surgical stabilization. Bilsky characterizes epidural tumor relationship to neural structures. Prognosis and systemic status determine the appropriate intensity of treatment. Selecting between conventional palliative radiation and SBRT must not depend solely on machine availability. Histology, local control goals, prior irradiation, fracture risk, and cord proximity must be evaluated. In follow-up, worsening pain after radiation must be critically assessed: it may represent transient flare, tumor progression, or a radiation-induced fracture.
🏷️

Keywords

Preferred DeCS/MeSH Descriptors:
RadiotherapyStereotactic Body RadiotherapySpinal NeoplasmsNeoplasm MetastasisSpinal Cord CompressionRadiotherapy, Image-GuidedProton Therapy
⭐

Why this chapter matters

The same vertebral metastasis may require radiation alone, separation surgery followed by SBRT, or simple palliative radiotherapy, depending on mechanical stability, neural compression, and systemic prognosis. Knowing radiotherapy techniques alone is insufficient. This chapter demonstrates how to incorporate SINS, Bilsky, advanced imaging, and prognostic scores before selecting radiation modalities, highlighting why SBRT's ablative power demands rigorous safety evaluations.

“Modern radiotherapy has substantially expanded the boundaries of local control in spinal tumors, notably through IMRT, IGRT, and SBRT. However, technological precision does not substitute proper patient selection. Stability, epidural extension, tumor biology, prognosis, and neural tolerance must be analyzed jointly to achieve local tumor ablation without adding preventable morbidity.”
✨

Chapter Highlights

🌐
Card 1 — Tumor Control Is Not Mechanical Stability
Tumor control vs stability

Radiotherapy can relieve pain and ablate neoplasms, but a mechanically unstable spine remains a structural failure. SINS must be part of the initial workup to identify patients needing surgical stabilization before radiation.

🩺
Card 2 — SBRT Demands Rigorous Selection
Ablative doses require precision

Higher ablative doses achieve superior local control in radioresistant tumors, but demand extreme precision. Neural anatomy, mechanical stability, prior radiation fields, and fracture risk must be weighed before choosing SBRT.

📐
Card 3 — Bilsky Grade Alters Strategy
Epidural disease directs treatment

The extent of epidural disease dictates whether radiotherapy can be applied directly or if upfront separation surgery is mandated. The anatomical relationship between tumor and the spinal cord is central to safety.

📑

How to Cite this Chapter (Vancouver Format)

Official bibliographic indexing and citation guidelines
📖 Pages: 753-766Vancouver Style
Authors (Vancouver):Hanriot RM, Gutierrez NS

Hanriot RM, Gutierrez NS. Radioterapia nos tumores de coluna. In: Pudles E, Defino H, Risso M, editors. Tratado de Cirurgia da Coluna Vertebral (Treatise of Spine Surgery). 1st ed. Rio de Janeiro: Dilivros Editora; 2026. p. 753-766.

ISBN: 978-85-8053-292-0 • 1.ª Edição • Dilivros Editora
📚

Bibliographic References

1. Coleman RE. Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev. 2001;27(3):165-176.
2. Guckenberger M, Allred C, Apte A, et al. Stereotactic body radiotherapy for spinal metastases: benefits and limitations. Semin Radiat Oncol. 2021;31(2):160-167.
3. Alcorn S, Cortés ÁA, Bradfield L, Brennan M, Dennis K, Diaz DA, et al. External Beam Radiation Therapy for Palliation of Symptomatic Bone Metastases: An ASTRO Clinical Practice Guideline. Pract Radiat Oncol. 2024;14(5):377-397.
4. Sahgal A, Whyne C, Soliman H, et al. Stereotactic body radiation therapy for spinal metastases: a new standard of care. Neuro Oncol. 2024;26(Supplement_1):S76-S85.
5. Sahgal A, Myrehaug S, Siva S, et al. Spinal cord dose tolerance to stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2021;109(5):1247-1256.
6. Guninski A, Gomez D, Guckenberger M, et al. Efficacy and safety of SBRT for spine metastases: a systematic review and meta-analysis. Radiother Oncol. 2023;190:109863.
7. Mohan R, Liu A, Brown P, et al. Proton therapy: clinical evidence and future directions. Lancet Oncol. 2020;21(2):e87-e97.
8. Mundy GR. Mechanisms of bone metastasis. Cancer. 1997;80(8 Suppl):1546-56.
9. Body JJ, Casimiro S, Costa L. Targeting bone metastases in prostate cancer: improving clinical outcomes. Nat Rev Urol. 2015;12(6):340-349.
10. Fisher CG, DiPaola CP, Ryken TC, Bilsky MH, Shaffrey CI, Berven SH, et al. A novel classification system for spinal instability in neoplastic disease. Spine. 2010;35(22):E1221-9.
11. Tokuhashi Y, Matsuzaki H, Oda H, Oshima M, Ryu J. A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine (Phila Pa 1976). 2005;30(19):2186-91.
12. Bilsky MH, Laufer I, Fourney DR, Groff M, Schmidt MH, Varga PP, et al. Reliability analysis of the epidural spinal cord compression scale. J Neurosurg Spine. 2010;13(3):324-328.
13. Schmidt GP, Reiser MF, Baur-Melnyk A. Whole-body MRI for the staging and follow-up of patients with metastasis. Eur J Radiol. 2009;70(3):393-400.
14. Mulyadi R, Rahmawati Z, Haryanto F, et al. Dynamic contrast-enhanced magnetic resonance imaging parameter changes as an early biomarker of tumor responses following radiation therapy in patients with spinal metastases. Radiat Oncol J. 2023;41(4):231-240.
15. Vandewinckele L, Claessens M, Deseyne P, et al. Overview of artificial intelligence-based applications in radiotherapy. Radiother Oncol. 2020;149:7805.
16. Demaria S, Bhardwaj N, McBride WH, Formenti SC. Combining radiotherapy and immunotherapy: a revived partnership. Int J Radiat Oncol Biol Phys. 2005;63(3):655-666.
17. Myrehaug S, Sahgal A, Hayashi M, Levivier M, Ma L, Martinez R, et al. Reirradiation spine stereotactic body radiation therapy for spinal metastases: systematic review. J Neurosurg Spine. 2017;27(4):428-435.
18. Gillespie TW, Sahgal A, Myrehaug S, et al. Efficacy and safety of SBRT for spine metastases: a systematic review and meta-analysis for preparation of an ESTRO practice guideline. Int J Radiat Oncol Biol Phys. 2023;117(3):487-497.
19. Gui C, Chen X, Sheikh K, et al. A machine learning tool for prediction of vertebral compression fracture following stereotactic body radiation therapy for spinal metastases. Radiother Oncol. 2025;194:110207.
20. Cox BW, Spratt DE, Lovelock M, Bilsky MH, Lis E, Ryu S, et al. International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2012;83(5):e597-e605.
21. Sahgal A, Whyne CM, Ma L, et al. Vertebral compression fractures after stereotactic body radiotherapy for spinal metastases. J Clin Oncol. 2013;31(28):3597-3604.
22. Berenson JR, Rosen LS, Howell A, Porter L, Coleman RE, Morley W, et al. Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases. Cancer. 2001;91(7):1191-1200.
23. Verellen D, De Ridder M, Linthout N, Tournel K, Soete G, Storme G. Innovations in image-guided radiotherapy. Nat Rev Cancer. 2007;7(12):949-960.
24. Burgess L, Rezkalla M, Klein G, Karagoz B, Santos GM, Malmirian M, et al. A machine learning tool for prediction of vertebral compression fracture following stereotactic body radiation therapy for spinal metastases. Radiother Oncol. 2025;208:110912.
25. Demaria S, Bhardwaj N, McBride WH, Formenti SC. Combining radiotherapy and immunotherapy: a revived partnership. Int J Radiat Oncol Biol Phys. 2005;63(3):655-666.
26. Bludau F, Welzel G, Reis T, Abo-Madyan Y, Sperk E, Schneider F, et al. Combined kyphoplasty and intraoperative radiotherapy (Kypho-IORT) versus external beam radiotherapy (EBRT) for painful vertebral metastases – a randomized phase III study. BMC Cancer. 2019;19(1):430.
Episode 06 – Early-Onset Scoliosis
Scheduled Premiere
Exclusive Premiere • Wednesday, October 07 at 9:00 PM (BRT)
Wednesday, October 07 at 9:00 PM (BRT)
The live countdown will be activated on the eve of the premiere.

The full videocast will premiere automatically in this player on Wednesday, 10/07 at 6:00 PM (BRT).

Also premiering on Spotify
Treatise in Debate

Official videocast derived from the treatise chapters.

Episode 06 – Early-Onset Scoliosis

Lungs and the Growing Spine: thoracic development, C-EOS classification, and growth-friendly surgical techniques